0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Please Wait... Processing your request... Please Wait.

Not a subscriber yet?

Published monthly, JAMA Neurology brings you an international perspective on a wide range of topics from the leading centers of neurological research. Subscribe/Learn More

Current Highlights

Follow Us

Original Investigation | September 26, 2016 ONLINE FIRST

Efficacy and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorders

This systematic review and meta-analysis evaluates the efficacy and safety of rituximab therapy in neuromyelitis optica spectrum disorders, considering the potential predictive factors related to patient response to rituximab in this disease.

Original Investigation | September 19, 2016 FREE ONLINE FIRST

Neurochemical Aftermath of Mild Traumatic Brain Injury

This study investigates whether persistent symptoms after mTBI are associated with brain injury as evaluated by cerebrospinal fluid biochemical markers for axonal damage and other aspects of central nervous system injury.
Editorial

Original Investigation | September 12, 2016 ONLINE FIRST

Endovascular Therapy for Acute Ischemic Stroke

This pooled cohort study evaluates the safety and effectiveness of endovascular therapy for occlusions of the M2 segment of the middle cerebral artery in patients with ischemic stroke.
Editorial

Original Investigation | September 6, 2016 ONLINE FIRST

Preclinical Assessment of Young Plasma for Alzheimer Disease

This preclinical study determines whether young blood plasma ameliorates pathology and cognition in a mouse model for AD.

Original Investigation | August 29, 2016 ONLINE FIRST

GBA Mutations and the E326K Polymorphism in Parkinson Disease

This cohort study examines the association of GBA mutations and E326K polymorphisms with progression of motor symptoms and cognitive decline in patients with Parkinson disease.

Explore more articles:  Current Issue | Online First

Multimedia >

Author Interview

Author photo

Interview with Vanda A. Lennon, MD, PhD, author of Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis, and Robert P. Lisak, MD, author of Expanding the Range of Diagnosable Autoimmune Encephalopathies and Encephalomyelopathies

audio player

RELATED ARTICLE:

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy A Novel Meningoencephalomyelitis

All Author Interviews >

Article Video

Video thumbnail

Episodic Dystonia (0:24)

Video EEG recording showing a typical event consisting of a rapid dystonia involving the right arm and associated with the patient’s described cycling auras.


All Article Videos >

Interactive

Interactive preview


All Interactive >

Author Readings
Author photo

audio player

RELATED ARTICLE:


Latest Quiz

All Quizzes >

A Young Man With Recurrent Coma and Refractory Status Epilepticus

A man in his 30s presented with a 5-day history of vomiting, followed by lethargy and confusion. Two years prior, he had been hospitalized with coma with no identifiable precipitant.

What is your diagnosis?

Image of JAMA forum logo

Physician Jobs